Tc-99m-PSMA imaging allows successful radioguided surgery in recurrent prostate cancer.
CONCLUSION: The use of radiolabeled PSMA (primary diagnosis with 68Ga, radioguided surgery with 99mTc and finally treatment with 177Lu) seems to be a major breakthrough in diagnosis and treatment of prostate cancer.
PMID: 30411731 [PubMed - as supplied by publisher]
Source: Hellenic Journal of Nuclear Medicine - Category: Nuclear Medicine Tags: Hell J Nucl Med Source Type: research
More News: Austria Health | Bladder Cancer | Cancer | Cancer & Oncology | CT Scan | Nuclear Medicine | Prostate Cancer | Prostatectomy